Rachel Haurwitz

Rachel Haurwitz

Founder chez CARIBOU BIOSCIENCES, INC.

Fortune : 18 M $ au 31/03/2024

38 ans
Health Technology
Commercial Services
Consumer Services

Profil

Rachel E.
Haurwitz
is the founder and has held multiple positions throughout her career.
She founded Caribou Biosciences, Inc. in 2011, where she currently serves as the President, Chief Executive Officer & Director.
In 2014, she also founded Intellia Therapeutics, Inc. and served as a Director until 2016.
In addition to her founding positions, Dr. Haurwitz currently holds several jobs.
Since 2020, she has been a Director at the Biotechnology Innovation Organization.
Since 2019, she has also been a Director at BIOCOM.
Furthermore, in 2021, she became an Independent Director at Seer, Inc. (California).
Dr. Haurwitz's education includes a doctorate from the University of California, Berkeley, and an undergraduate degree from Harvard College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/02/2024 3 508 095 ( 3,88% ) 18 M $ 31/03/2024
14/06/2023 29 437 ( 0,05% ) 55 930 $ 31/03/2024

Postes actifs de Rachel Haurwitz

SociétésPosteDébut
CARIBOU BIOSCIENCES, INC. Founder 28/10/2011
SEER, INC. Director/Board Member 08/11/2021
Director/Board Member 26/02/2019
Director/Board Member 01/02/2020
Tous les postes actifs de Rachel Haurwitz

Anciens postes connus de Rachel Haurwitz

Formation de Rachel Haurwitz

University of California, Berkeley Doctorate Degree
Harvard College Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Rachel Haurwitz

Relations

100 +

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
CARIBOU BIOSCIENCES, INC.

Health Technology

INTELLIA THERAPEUTICS, INC.

Health Technology

SEER, INC.

Health Technology

Entreprise privées2

Commercial Services

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Rachel Haurwitz